Often called the “hepatocellular integrity assay,” the Hepatitis B Surface Antigen (HBsAg) test is a vital diagnostic method for determining whether the hepatitis B virus (HBV) is present in the blood. A crucial sign for distinguishing between acute and chronic hepatitis B infection is HBsAg, which is the first detectable viral antigen to emerge throughout infection. Its existence suggests that the individual is contagious and might be in danger of infecting other people.
The hepatocellular integrity assay’s description includes the term “health heart diagnostics” (HHD), which emphasizes the assay’s significance for cardiovascular and liver health. Prolonged hepatitis B infection can result in severe liver damage, such as cirrhosis and liver cancer, which can have a significant impact on the cardiovascular system.